drugset / Trial / NCT03107169

Treatment of Initial Clostridium Difficile Infection

NCT03107169

Completed 10 enrolled Autonomous University of Nuevo León
RandomizedParallel-groupSingle-blindTreatment

Summary

Investigators designed an open, two-arm study to compare oral vancomycin with a fecal microbiota transplant (FMT) from a fecal donor-unrelated donor mix (FURM) as treatments for the first Clostridium difficile infection (CDI) episode among hospitalized patients.

Timeline

Start
2015-02-01
Primary completion
2015-09-30
Completion
2015-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Vancomycin Other / unclassified 250 mg Oral